• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×
  • 27 Jan 17
title

Most popular equity research this week | 23-27 Jan

  • 1014 views
James Valentine

Digital editor at Research Tree

 
Mac Trending
Strap line

Check out this week's most popular equity research

Companies: BMS, BT/A, CRTA, DGE, FEVR, HCHOF, 73S, VLG


Body

 

Growth Prospects in Healthcare

Sector note | Panmure Gordon, 26 January

 

"We expect the volatility of the last 3 months to continue, with macro events, particularly the uncertainty brought by President Trump and his focus on pharma pricing and dismantling the Affordable Care Act, likely to keep healthcare in the headlines for the wrong reasons. We believe the more highly valued larger stocks are likely to struggle to break out to new trading levels but note there remains good value within the smaller end of the sector for stockpickers, with company-specific events likely to drive some stocks well ahead of the crowd..."

 

Driving distribution – price target raised

Fevertree Drinks Plc (FEVR) | Whitman Howard, 26 January

 

"Fever Tree’s (FEVR LN, HOLD, T/P 1250p) strong second half trading statement and clear ability to drive distribution forward this calendar year prompts us to upgrade both our full year 2016 and 2017 forecasts as well as raise our price target from 1080p to 1250p, which implies a full valuation for now..."

 

H1: growth momentum maintained in all markets

Diageo (DGE) | AlphaValue, 26 January

 

"H1 update: organic volumes were up +1.8% (cons. +2%) whereas net sales grew organically +4.4% (cons. 3.1%, AV +4.1%) with the price/mix at +2.7%. On a reported basis, net sales were up +15% (FX: 15.2%). Organic net sales by region: North America +3% (cons. +3.2%), Europe +5% (cons. +3.1%), Africa +4% (cons. +4%), LatAm +11% (cons. +2%), and Asia Pacific +3% (cons. +3.5%). Organic volume growth by region: North America +1%, Europe +3%, Africa +3%, LatAm +0%, Asia Pacific +2%. The operating margin for the period was up 150bp on reported basis (to 32.6% vs. cons. 31.4%) and flat organically. The profit attributable to shareholders is up +8% to $1,514m. The interim dividend is 23.7p (+5% yoy). The group maintains its guidance of mid single-digit top-line growth and a 100bp improvement in the organic operating margin in the three years ending 30 June FY19..."

 

Another good year

Safestyle UK Plc (SFE) | Zeus Capital, 23 January

 

"Today’s trading update highlights that 2016 has been another good year for Safestyle reporting record revenue, that will translate into record profitability, and continuing to take market share. Revenue of £163.5m (FY15: £148.9m) is broadly in line with the ZC estimate of £165.0. Profitability is in line with management expectations and will be in line with consensus and the ZC estimate of £20.2m. Safestyle has grown revenue and profit by c. 10.0% and c. 15.0%, respectively, during FY16. This level of growth looks to be at the upper end of the peer group’s performance in a year when the sector has had to deal with the continuing difficult RMI market and input price pressures, as raw material costs increase. Safestyle’s best in class performance has been reflected in the share price which is trading near all-time highs at 311.75p. Despite this, the FY17 PER multiple of 15.3x does not look stretched when taking into account the competitive position of the business in its market and the potential for further cash returns..." 

 

Chocs away!

Hotel Chocolat Group Plc (HOTC) | finnCap, 27 January


"We initiate on Hotel Chocolat with a 270p price target and Hold rating. While the investment case is attractive, capturing production efficiencies accounts for half of the 21% PBT CAGR forecast to FY19E. Any slippage in the timing of related capital projects or resulting production disruption could weigh on the stock, which at 37x forward earnings is, in our view, priced for perfection. With the share price up 90% since IPO last year, we suggest investors await a more favourable entry point..."


Turning point

WANdisco Plc (WAND) | Edison, 23 January

 

"WANdisco’s performance in H2 indicates that its investment in creating a platform for scalable growth is starting to reap returns. H2 bookings grew by 109%, costs reduced and in Q4 the company operated at close to cash-flow break even. The pipeline entering FY17 is strong and with three major tech partners – IBM, Oracle and Amazon – now generating sales, WANdisco looks exceptionally well placed to continue benefitting from the growth in cloud storage and big data..."

 

Cyclical challenges continue

Braemar Shipping Services Plc (BMS) | Edison, 24 January

 

"While the shipbroking activity continues to trade in line with expectations, weakness in the oil & gas market has continued to adversely impact the Technical division. Corrective actions have been accelerated, with £6m of benefit expected in FY18. FY17 EBIT guidance is cut to £3-3.5m and the reduced dividend should more closely reflect the underlying earnings potential, with an historic yield of 5.7% likely to build as earnings recover..."

 

A Year of Maiden Profitability

Venture Life Group Plc (VLG) | Equity Development, 26 January

 

"Venture Life Group manages a growing portfolio of non-prescription healthcare brands focused on ageing consumers, supported by its integrated product development and manufacturing model. The shares trade on a low multiple, particularly given that VLG will report positive EBITDA in 2016, has revenue momentum and prospects of near-term, self-sustaining profitability..."

 

Good progress across 2016

WANdisco Plc (WAND) | Progressive Equity Research, 26 January

 

"Following our notes on WANdisco in July and August (which focused on the IBM relationship and the Smart City deal) this brief comment summarises how the group has fared during 2016 and sets the scene for 2017. Alongside the major agreement with IBM, WANdisco produced encouraging interim results, announced significant contract wins and raised new equity. We highlight good arket engagement in the form of new contracts and note the record bookings and excellent progress towards its target of neutralising the monthly cash burn during Q4. The group ended 2016 with net cash of U$7.6 million, a strong order book and good sales pipeline..."

 

BT, Profits Warning, But Dividend Maintained

BT Group (BT/) | Beaufort Securities, 25 January

 

"BT Group PLC (BT.A) reported a very unexpected profits warning this morning, coming from two sources. Firstly, management has uncovered “specific accounting manipulation” in its Italian business, covering “many people over a number of years”. Secondly, the outlook for BT’s UK public sector and International corporate markets has deteriorated which will manifest itself in Q4 and beyond. On the positive side, BT’s free cash flow (FCF) outlook remains high enough to allow BT to maintain its 10% dividend growth guidance for fiscal year’s 2017 and 2018. BT will report its Q3 results this Friday, so there will be more clarity on these issues, but with the stock now trading on only 5.6x FY-18 EV/EBITDA and yielding 5.4%, we retain our Buy recommendation with Target Price now 360p (previously 440p)..."

 


Body Two

Body Three

Body Four

Body Five

The information contained within this post is based on personal experience and opinion and should not be considered as a recommendation to trade nor financial advice.

More Content

More Content

Opportunities from turbulence

Companies: Braemar PLC

Canaccord Genuity

Implications of Trumponomics for equities

Companies: PWTN0QMWAHTBMSHILSHTGFOURULEVCTWEIRNFGBLTGCOBCHGMCROHNGBUR

Research Tree

Morning Note – 20 May 2025

Companies: TRT VLG IXI GETB XSG HDD CLX POLB AMCO

Cavendish

Executive interview - WANdisco, CEO David Richards

Companies: Cirata Plc

Edison

Venture Life Group - Consumer healthcare opportunity

Companies: Venture Life Group Plc

Cavendish
next
 
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Acquisdata
      • Actinver
      • Actio Advisors
      • Asset TV
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD (hosted by Progressive)
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In